FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

929360081000036101: Medicinal product pack reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


15976 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product pack reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1740441059
Medicinal product pack reference set Developed by Australian Digital Health Agency true Inferred relationship Some 991480534
Medicinal product pack reference set Is a Simple type reference set true Inferred relationship Some

Members
pegvisomant 20 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
somatropin 4 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
somatropin 1 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 1 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 1.2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 1.2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 1.4 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 1.4 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 1.6 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 1.8 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 2 mg injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 200 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 200 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 600 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
somatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 1 dual chamber syringe
somatropin 800 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
measles 1000 CCID50 units + mumps 25 119 CCID50 units + rubella 1000 CCID50 units + varicella-zoster 1995 PFU live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL ampoule], 1 pack
measles 1000 CCID50 units + mumps 5000 CCID50 units + rubella 1000 CCID50 units live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL ampoule], 1 pack
varicella-zoster live vaccine 1995 PFU injection [1 vial] (&) inert substance diluent [0.5 mL ampoule], 1 pack
meningococcal A 5 microgram + meningococcal C 5 microgram + meningococcal W135 5 microgram + meningococcal Y 5 microgram conjugate vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
meningococcal quadrivalent polysaccharide vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
meningococcal C conjugate vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
measles 1000 CCID50 units + mumps 25 119 CCID50 units + rubella 1000 CCID50 units + varicella-zoster 1995 PFU live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
measles 1000 CCID50 units + mumps 5000 CCID50 units + rubella 1000 CCID50 units live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
varicella-zoster live vaccine 1995 PFU injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
yellow fever live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
meningococcal quadrivalent polysaccharide vaccine injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack
rubella live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack
omalizumab 75 mg injection [1 vial] (&) inert substance diluent [0.6 mL ampoule], 1 pack
stannous chloride dihydrate 50 microgram injection [1 vial] (&) inert substance diluent [0.6 mL syringe] (&) inert substance diluent [1 mL syringe], 1 pack
varicella-zoster live vaccine 19 400 PFU injection [1 vial] (&) inert substance diluent [0.65 mL syringe], 1 pack
varicella-zoster live vaccine 19 400 PFU injection [1 vial] (&) inert substance diluent [0.65 mL vial], 1 pack
varicella-zoster live vaccine 1350 PFU injection [1 vial] (&) inert substance diluent [0.7 mL syringe], 1 pack
measles 1000 TCID50 units + mumps 12 500 TCID50 units + rubella 1000 TCID50 units injection [1 vial] (&) inert substance diluent [0.7 mL vial], 1 pack
varicella-zoster live vaccine 1350 PFU injection [1 vial] (&) inert substance diluent [0.7 mL vial], 1 pack
lutropin alfa 75 units injection [1 vial] (&) inert substance diluent [1 mL ampoule], 1 pack
palivizumab 100 mg injection [1 vial] (&) inert substance diluent [1 mL ampoule], 1 pack
palivizumab 50 mg injection [1 vial] (&) inert substance diluent [1 mL ampoule], 1 pack
rabies vaccine injection [1 vial] (&) inert substance diluent [1 mL ampoule], 1 pack
leuprorelin acetate 7.5 mg modified release injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber syringe
methylprednisolone 40 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber vial
methylprednisolone 40 mg injection [1 chamber] (&) inert substance diluent [1 x 1 mL chamber], 5 dual chamber vials
somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber cartridge
somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device
somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 5 dual chamber pen devices
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber cartridge
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device
somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 5 dual chamber pen devices
somatropin 5.3 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber cartridge
rabies vaccine injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack
somatropin 10 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack
susoctocog alfa 500 units injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack
lutropin alfa 75 units injection [1 vial] (&) inert substance diluent [1 mL vial], 1 pack
somatropin 1.33 mg injection [1 vial] (&) inert substance diluent [1 mL vial], 1 pack
somatropin 1.33 mg injection [1 vial] (&) inert substance diluent [1.13 mL vial], 1 pack
omalizumab 150 mg injection [1 vial] (&) inert substance diluent [1.2 mL ampoule], 1 pack
ziprasidone 20 mg injection [1 vial] (&) inert substance diluent [1.2 mL ampoule], 1 pack
somatropin 8 mg injection [1 vial] (&) inert substance diluent [1.37 mL cartridge], 1 pack
leuprorelin acetate 22.5 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 30 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 45 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
Mycobacterium bovis (BCG) live vaccine injection [1 vial] (&) inert substance diluent [1.5 mL vial], 1 pack
temsirolimus 25 mg injection [1 vial] (&) inert substance diluent [1.8 mL vial], 1 pack
inert substance diluent [1 x 10 mL ampoule] (&) pamidronate disodium 60 mg injection [1 x 60 mg vial], 1 pack (medicinal product pack)
pamidronate disodium 90 mg injection [1 vial] (&) inert substance diluent [10 mL ampoule], 1 pack
polyvalent Central American and South American snake antivenom injection [10 mL vial] (&) inert substance diluent [10 mL ampoule], 1 pack
rifampicin 600 mg injection [1 vial] (&) inert substance diluent [10 mL ampoule], 1 pack
tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack
melphalan 50 mg injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
octocog alfa 1000 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
octocog alfa 250 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
octocog alfa 500 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
protein C 1000 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
vincristine sulfate 1 mg injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
vonicog alfa 1300 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
methylprednisolone 1 g injection [1 vial] (&) inert substance diluent [16 mL vial], 1 pack
inert substance diluent [1 x 2 mL ampoule] (&) lanreotide 30 mg modified release injection [1 x 30 mg vial], 1 pack (medicinal product pack)
leuprorelin acetate 3.75 mg modified release injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack
parecoxib 40 mg injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack
triptorelin 11.25 mg injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack
triptorelin 22.5 mg injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack
triptorelin 3.75 mg injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack
methylprednisolone 125 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial
octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
pasireotide (as embonate) 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
pasireotide (as embonate) 40 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
pasireotide (as embonate) 60 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
risperidone 25 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
risperidone 37.5 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
risperidone 50 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
octocog alfa 1000 units injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack

Start Previous Page 91 of 160 Next End


Reference Sets

Reference set descriptor

Back to Start